NYSE:MDTMedical Equipment
Assessing Medtronic (MDT) Valuation After Affera Deal And Cardiac Ablation Growth Outlook
Medtronic (MDT) is back in focus after recent analyst coverage spotlighted its Affera acquisition and the Cardiac Ablation Solutions segment, where the company projects an extra US$1b in sales by 2027.
See our latest analysis for Medtronic.
Medtronic’s recent Affera headlines come as the share price trades at US$102.96, with a 30 day share price return of 7.18% and a 90 day share price return of 13.52%. The 1 year total shareholder return of 16.94% suggests momentum has been building over the...